EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Diagnostic Value of Plasma Small Extracellular Vesicle‐Derived CAIX Protein in Prostate Cancer and Clinically Significant Prostate Cancer: A Study on Predictive Models

Haotian Chen, Bairen Pang iD, Zhihan Liu, Benjie Li, Qi Wang, Baokun Fan, Meng Han, Jie Gong, Cheng Zhou, Yingzhi Chen, Yong Li iD, Junhui Jiang

The Prostate · 2025

DOI: 10.1002/pros.24879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Prostate, 2025. Verfasst von Haotian Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Ningbo University, Health Science Center, Ningbo University, Ningbo, Zhejiang, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Carbonic Anhydrase IX, Extracellular Vesicles, Biomarkers, Tumor. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This study was supported by Ningbo Major Research and Development Plan Project, Ningbo Science Foundation, Basic Public Welfare Research Project of Zhejiang Pr….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Current diagnostic tools are inaccurate and not specific to prostate cancer (PCa) diagnosis. Cancer‐derived small extracellular vehicles (sEVs) play a key role in intercellular communication. In this study, we examined the diagnostic value of plasma sEV‐derived carbonic anhydrase IX (CAIX) protein for PCa and clinically significant prostate cancer (csPCa) diagnosis and avoiding unnecessary biopsies.

Methods

Plasma samples ( n = 230) were collected from the patients who underwent prostate biopsy with elevated prostate‐specific antigen (PSA) levels. sEVs were isolated and characterized, and sEV protein CAIX was measured using an enzyme‐linked immunosorbent assay. Independent predictors of csPCa (Gleason score ≥ 7) were identified, and a predictive model was established. A Nomogram for predicting csPCa was developed using data from the training cohort.

Results

The expression of sEV protein CAIX was significantly higher in both PCa and csPCa compared to benign patients and nonsignificant PCa (nsPCa) (Gleason score < 7, p < 0.001). sEV protein CAIX performed well in distinguishing PCa from benign patients. The predictive model defined by sEV protein CAIX and PSA density (PSAD) demonstrated the highest discriminative ability for csPCa (AUC = 0.895), with diagnostic sensitivity and specificity of 82.5% and 85.8%, respectively. Furthermore, sEV protein CAIX is an effective predictor of 2‐year biochemical recurrence (BCR) in PCa patients ( p = 0.013), and its high expression is significantly associated with poorer BCR‐free survival ( p < 0.05).

Conclusions

Our findings demonstrate the excellent performance of sEV protein CAIX in PCa and csPCa diagnosis. The Nomogram‐based csPCa predictive model incorporating sEV protein CAIX and PSAD exhibits strong predictive value. Additionally, assessing plasma sEV protein CAIX expression levels can further aid in evaluating patient prognosis and provide a basis for making effective treatment decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsCarbonic Anhydrase IXExtracellular VesiclesBiomarkers, TumorAntigens, NeoplasmHumansMaleAgedMiddle AgedPredictive Value of TestsProstate-Specific AntigenNomogramsNeoplasm Grading

Stichwörter der Autor:innen

CAIXPSAdiagnosisextracellular vesicleprostate cancer

Substanzen

Carbonic Anhydrase IXBiomarkers, TumorAntigens, NeoplasmProstate-Specific AntigenCA9 protein, human

Autor:innen und Institutionen

  • The First Affiliated Hospital of Ningbo University, Health Science Center, Ningbo University, Ningbo, Zhejiang, China.
  • Ningbo Clinical Research Center for Urological Disease, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.
  • Translational Research Laboratory for Urology, Department of Urology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.
  • Zhejiang Engineering Research Center of Innovative Technologies and Diagnostic and Therapeutic Equipment for Urinary System Diseases, Ningbo, Zhejiang, China.
  • Cancer Care Centre, St George Hospital, Kogarah, New South Wales, Australia.
  • St. George and Sutherland Clinical Campuses, School of Clinical Medicine, UNSW Sydney, Kensington, New South Wales, Australia.

ORCID-Profile: Bairen Pang, Yong Li

Förderung

  • This study was supported by Ningbo Major Research and Development Plan Project, Ningbo Science Foundation, Basic Public Welfare Research Project of Zhejiang Pr…

Zitieren

APA

Chen, H., Pang, B., Liu, Z., Li, B., Wang, Q., Fan, B., Han, M., Gong, J., Zhou, C., Chen, Y., Li, Y., & Jiang, J. (2025). The Diagnostic Value of Plasma Small Extracellular Vesicle‐Derived CAIX Protein in Prostate Cancer and Clinically Significant Prostate Cancer: A Study on Predictive Models. The Prostate. https://doi.org/10.1002/pros.24879

Vancouver

Chen H, Pang B, Liu Z, Li B, Wang Q, Fan B, et al. The Diagnostic Value of Plasma Small Extracellular Vesicle‐Derived CAIX Protein in Prostate Cancer and Clinically Significant Prostate Cancer: A Study on Predictive Models. The Prostate. 2025. doi:10.1002/pros.24879

BibTeX
@article{Chen2025,
  author = {Chen, Haotian and Pang, Bairen and Liu, Zhihan and Li, Benjie and Wang, Qi and Fan, Baokun and Han, Meng and Gong, Jie and Zhou, Cheng and Chen, Yingzhi and Li, Yong and Jiang, Junhui},
  title = {The Diagnostic Value of Plasma Small Extracellular Vesicle‐Derived CAIX Protein in Prostate Cancer and Clinically Significant Prostate Cancer: A Study on Predictive Models},
  journal = {The Prostate},
  year = {2025},
  doi = {10.1002/pros.24879}
}
Kostenlos starten →